Types of Strokes Seen in Patients

Related

• 

  First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability

  Pravin U. Dugel, MD

  Annual Meeting Talks

  2019

• 

  A Phase I Study to Evaluate the Tie2 Agonist RO7446603, Alone or in Combination With Aflibercept orFaricimab, in Diabetic Macular Edema

  Jeremiah Brown, MD, MS, FASRS

  Annual Meeting Talks

  2025

• 

  Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study

  Priyatham (Prithu) S Mettu, MD

  Updates from the Field

  2019